Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following Peg-interferon and ribavirin treatment

被引：1
|
作者：
Aladag, M [1 ]
Camci, C [1 ]
Huang, Y [1 ]
Wright, H [1 ]
Rizvi, S [1 ]
Gurakar, A [1 ]
Stokes, K [1 ]
Sebastian, A [1 ]
机构：
[1] Integris Baptist Med Ctr, Nazih Zuhdi Transplantat Inst, Div Liver Transplantat Med Hepatol, Oklahoma City, OK 73112 USA
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2005年 / 39卷 / 10期
关键词：
D O I：
10.1097/01.mcg.0000180801.64575.4f
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：923 / 924
页数：2
相关论文
共 50 条
  • [41] Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice
    Cavalletto, Luisa
    Bernardinello, Elisabetta
    Diodati, Giulio
    Raise, Enzo
    Gatta, Angelo
    Chemello, Liliana
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (04) : 173 - 181
  • [42] Acquired endocrine disorders after peg-interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Wang, T-E
    Chen, M-J
    Liou, T-C
    Wang, H-Y
    Chu, C-H
    Chen, C-J
    Hu, K-C
    Shih, S-C
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A181 - A182
  • [43] peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may induce working memory disturbances in chronic hepatitis C (CHC) patients
    Pawelczyk, T.
    Strzelecki, D.
    Pawelczyk, A.
    Rabe-Jablonska, J.
    EUROPEAN PSYCHIATRY, 2007, 22 : S303 - S303
  • [44] Neutralizing antibodies to interferon alpha in chronic hepatitis C patients non-responding to pegylated interferon plus ribavirin retreated to PEG-interferon α2a and ribavirin (ANRS gammatri)
    Halfon, Philippe
    Perusat, Sophie
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Trimoulet, P.
    Benhamou, Yves
    Leroy, V.
    Marcellin, Patrick
    Foucher, J.
    Chene, Genevieve
    Couzigou, Patrice
    HEPATOLOGY, 2007, 46 (04) : 669A - 669A
  • [45] Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin
    Nkuize, M.
    Mulkay, J. -P.
    Adler, M.
    Lasser, L.
    Michielsen, P.
    de Galocsy, C.
    Assene, C.
    Delwaide, J.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (03) : 291 - 299
  • [46] Low-dose PEG-interferon alpha and ribavirin for recurrent hepatitis C virus after liver transplantation
    Fontana, Massimiliano
    Ciuffreda, Donatella
    Moradpour, Darius
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 258 - 258
  • [47] Efficacy of daily consensus interferon and ribavirin compared to PEG-interferon α-2b and ribavirin in non-responders with chronic Hepatitis C
    Dollinger, MM
    Dridi, Y
    Lesske, J
    Behl, S
    Fleig, WE
    HEPATOLOGY, 2005, 42 (04) : 691A - 692A
  • [48] Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C
    Bayati, N
    Silverman, AL
    Gordon, SC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (12): : 2452 - 2456
  • [49] Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation
    Pawelczyk, T.
    Strzelecki, D.
    Pawelczyk, A.
    Rabe-Jablonska, J.
    EUROPEAN PSYCHIATRY, 2007, 22 : S303 - S304
  • [50] Serial Changes in Alpha-Fetoprotein Levels During Therapy for Chronic Hepatitis C
    Senol, Altug
    Akin, Mete
    Songur, Yildiran
    Isler, Mehmet
    Kockar, M. Cem
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7 (01) : 23 - 26
12345